Cargando…

Bioinformatics analysis identification of AKT3 and RAC1 as key genes in postmenopausal osteoporosis

Postmenopausal osteoporosis (PMO) is an aging-associated disease that manifests as degradation of bone tissue microstructure leading to decreased bone mass and increased bone fragility. Differentiation of peripheral blood mononuclear cells into osteoclasts is an important process in the development...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Liyong, Li, Xiaoming, Wan, Chunfei, Da, Weiwei, Zhang, Jun, Fan, Lihong, Fu, Qiang, Xing, Shunmin, Wang, Yongxiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2022
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9475336/ https://www.ncbi.nlm.nih.gov/pubmed/36168425 http://dx.doi.org/10.3892/etm.2022.11592

Ejemplares similares

Screening for Key Pathways Associated with the Development of Osteoporosis by Bioinformatics Analysis
por: Liu, Yanqing, et al.
Publicado: (2017)

Investigation of candidate genes and mechanisms underlying postmenopausal osteoporosis using bioinformatics analysis
por: Zhu, Xiaozhong, et al.
Publicado: (2018)

Postmenopausal Osteoporosis
por: Kamel, Hosem K.
Publicado: (2006)

Bioinformatics Analysis Reveals the Altered Gene Expression of Patients with Postmenopausal Osteoporosis Using Liuweidihuang Pills Treatment
por: Gong, Rui, et al.
Publicado: (2019)

Identification of biomarkers associated with diagnosis of postmenopausal osteoporosis patients based on bioinformatics and machine learning
por: Huang, Xinzhou, et al.
Publicado: (2023)

FOXO4 May Be a Biomarker of Postmenopausal Osteoporosis
por: Yang, Weiwei, et al.
Publicado: (2022)

Botanicals in Postmenopausal Osteoporosis
por: Słupski, Wojciech, et al.
Publicado: (2021)

Corrigendum to “Bioinformatics Analysis Reveals the Altered Gene Expression of Patients with Postmenopausal Osteoporosis Using Liuweidihuang Pills Treatment”
por: Gong, Rui, et al.
Publicado: (2019)

Molecular Subtype Classification of Postmenopausal Osteoporosis and Immune Infiltration Microenvironment Based on Bioinformatics Analysis of Osteoclast-Regulatory Genes
por: Gong, Yining, et al.
Publicado: (2023)

Identification of key immune genes of osteoporosis based on bioinformatics and machine learning
por: Hao, Song, et al.
Publicado: (2023)

Association of dyslipidaemia with osteoporosis in postmenopausal women
por: Zhang, Lingnan, et al.
Publicado: (2021)

Bazedoxifene for the prevention of postmenopausal osteoporosis
por: Gennari, Luigi, et al.
Publicado: (2008)

Intravenous bisphosphonates for postmenopausal osteoporosis
por: Mottaghi, Peyman
Publicado: (2010)

Treatment options for postmenopausal osteoporosis
por: Walsh, Garry M
Publicado: (2012)

Postmenopausal osteoporosis: Our experience
por: Mehrotra, R. N., et al.
Publicado: (2012)

Primary osteoporosis in postmenopausal women
por: Ji, Meng-Xia, et al.
Publicado: (2015)

Yeast Hydrolysate and Postmenopausal Osteoporosis
por: Hong, Yang Hee, et al.
Publicado: (2023)

Trehalose delays postmenopausal osteoporosis by enhancing AKT/TFEB pathway‑dependent autophagy flow in rats
por: Wang, Yongli, et al.
Publicado: (2023)

Pharmacogenomics Study for Raloxifene in Postmenopausal Female with Osteoporosis
por: Lu, Hsing-Fang, et al.
Publicado: (2020)

Identification of miR-194-5p as a potential biomarker for postmenopausal osteoporosis
por: Meng, Jia, et al.
Publicado: (2015)

Exosomes derived from human umbilical cord mesenchymal stem cells promote osteogenesis through the AKT signaling pathway in postmenopausal osteoporosis
por: Ren, Shi-Wei, et al.
Publicado: (2022)

Identifying a possible new target for diagnosis and treatment of postmenopausal osteoporosis through bioinformatics and clinical sample analysis
por: Liu, Ting, et al.
Publicado: (2021)

Identification of key pathways and genes in carotid atherosclerosis through bioinformatics analysis of RNA-seq data
por: Li, Zhongchen, et al.
Publicado: (2021)

A meta-analysis of VDR polymorphisms and postmenopausal osteoporosis
por: Fu, Lijuan, et al.
Publicado: (2020)

The prevalence and treatment rate trends of osteoporosis in postmenopausal women
por: Zhang, Xiaojuan, et al.
Publicado: (2023)

Medical examination powers miR-194-5p as a biomarker for postmenopausal osteoporosis
por: Ding, Haifeng, et al.
Publicado: (2017)

Efficacy and safety of bazedoxifene for postmenopausal osteoporosis
por: Kawate, Hisaya, et al.
Publicado: (2011)

Once-monthly risedronate for postmenopausal osteoporosis
por: Casadei, Kristina, et al.
Publicado: (2010)

Profile of teriparatide in the management of postmenopausal osteoporosis
por: Sikon, Andrea, et al.
Publicado: (2010)

Lasofoxifene for the prevention and treatment of postmenopausal osteoporosis
por: Lewiecki, E Michael
Publicado: (2009)

New Antiresorptive Therapies for Postmenopausal Osteoporosis
por: Choi, Hee-Jeong
Publicado: (2015)

Effects of Yogasanas on osteoporosis in postmenopausal women
por: Motorwala, Zainab S, et al.
Publicado: (2016)

Risk Factors for Osteoporosis in Postmenopausal Women
por: Bijelic, Radojka, et al.
Publicado: (2017)

Introduction to the Guidelines on Menopause and Postmenopausal Osteoporosis
por: Meeta, Meeta
Publicado: (2020)

Long-Term Treatment of Postmenopausal Osteoporosis
por: Brown, Jacques P.
Publicado: (2021)

T-Cell Mediated Inflammation in Postmenopausal Osteoporosis
por: Wu, Di, et al.
Publicado: (2021)

Anabolic treatments for osteoporosis in postmenopausal women
por: Hassan, Neelam, et al.
Publicado: (2021)

Efficacy and Mechanisms of Oleuropein in Postmenopausal Osteoporosis
por: Liu, Huilan, et al.
Publicado: (2022)

Postmenopausal Osteoporosis: A Literature Review
por: Bhatnagar, Aayushi, et al.
Publicado: (2022)

The role of melatonin in the development of postmenopausal osteoporosis
por: Yang, Keda, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2ko1gugtfi1fdsigvhohs18g94